Nadine Karaki

Dr. Nadine Karaki


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
NKNadine Karaki
Nadine Karaki
AAAbdulhadi Aljawish
Abdulhadi Aljawish
CHCatherine Humeau
Catherine Humeau
LMLionel Muniglia
Lionel Muniglia
JJJordane Jasniewski
Jordane Jasniewski

22 April 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Mohamed SallaMohamed Salla
Mohamed Salla
NKNadine Karaki
Nadine Karaki
Belal Adib El KaderiBelal Adib El Kaderi
Belal Adib El Kaderi
AAAbeer Ayoub
Abeer Ayoub
SYSamar Nemer Younes
Samar Nemer Younes
Sami El KhatibSami El Khatib
Sami El Khatib
Overcoming the limited bioavailability and extensive metabolism of effective in vitro drugs remains a challenge that limits the translation of promising drugs into clinical trials. Resveratrol, despite its well-reported therapeutic benefits, is not metabolically stable and thus has not been utilized as an effective clinical drug. This is because it needs to be consumed in large amounts to overcome the burdens of bioavailability and conversion into less effective metabolites. Herein, we summarize the more relevant approaches to modify resveratrol, aiming to increase its biological and therapeutic efficacy. We discuss combination therapies, derivatization, and the use of resveratrol nanoparticles. Interestingly, the combination of resveratrol with established chemotherapeutic drugs has shown promising therapeutic effects on colon cancer (with oxaliplatin), liver cancer (with cisplatin, 5-FU), and gastric cancer (with doxorubicin). On the other hand, derivatizing resveratrol, including hydroxylation, amination, amidation, imidation, methoxylation, prenylation, halogenation, glycosylation, and oligomerization, differentially modifies its bioavailability and could be used for preferential therapeutic outcomes. Moreover, the encapsulation of resveratrol allows its trapping within different forms of shells for targeted therapy. Depending on the nanoparticle used, it can enhance its solubility and absorption, increasing its bioavailability and efficacy. These include polymers, metals, solid lipids, and other nanoparticles that have shown promising preclinical results, adding more “hype” to the research on resveratrol. This review provides a platform to compare the different approaches to allow directed research into better treatment options with resveratrol.

1 October 2016 in Food Hydrocolloids
Verified
Journal Article
Closed access
NKNadine Karaki
Nadine Karaki
AAAbdulhadi Aljawish
Abdulhadi Aljawish
LMLionel Muniglia
Lionel Muniglia
CHCatherine Humeau
Catherine Humeau
JJJordane Jasniewski
Jordane Jasniewski

1 September 2017 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
NKNadine Karaki
Nadine Karaki
AAA. Aljawish
A. Aljawish
LML. Muniglia
L. Muniglia
SBSabine Bouguet-Bonnet
Sabine Bouguet-Bonnet
SLSébastien Leclerc
Sébastien Leclerc
CHC. Humeau-Virot
C. Humeau-Virot

1 February 2017 in Asian Pacific Journal of Tropical Biomedicine
Verified
Journal Article
Open access
MHMarianne Haddad
Marianne Haddad
SZSalam Zein
Salam Zein
HSHawraa Shahrour
Hawraa Shahrour
KHKamar Hamadeh
Kamar Hamadeh
NKNadine Karaki
Nadine Karaki
HKHussein Kanaan
Hussein Kanaan
Objective: To extract and identify the chemical composition of the polysaccharide isolated from the Eucalyptus cultivated in Lebanon and to evaluate its antioxidant activity. Materials: The water-soluble polysaccharide was isolated from Eucalyptus leaves, and its structure was identified by Fourier transform infrared spectroscopy, proton nuclear magnetic resonance, and carbon-13 nuclear magnetic resonance. The antioxidant activity of the active ingredient was screened for its radical scavenging ability using 2,2-diphenyl-1-picryl-hydrazyl radical (DPPH) test. Results: The results of the DPPH test have shown that fucoidan, the polysaccharide isolated from Eucalyptus, exhibited almost the same antioxidant activity against DPPH· as the ascorbic acid did at 100 μg/mL. Conclusions: This natural molecule extracted from a medicinal plant has a promising antioxidant activity and could be used in pharmaceutical and medical applications

28 October 2012 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
SESebaaly
Sebaaly
NKNadine Karaki
Nadine Karaki
Antonio EvidenteAntonio Evidente
Antonio Evidente
In addition to their high nutritional value, red algae are of great interest as a source of therapeutic substances. However, despite their abundance on the Lebanese coast red algae have never been studied before. Therefore, we attempted to study among the available biomass one of the species of red algae growing on the Lebanese coast “Pterocladia”. We performed the extraction of trace elements, fatty acids, sulfated galactans and water-soluble polysaccharides of the phycocolloids family (carrageenans) whose physicochemical gelling or stabilizing effects attract many industrial sectors. The analysis of trace elements shows large amounts of potassium, calcium, silicon and iron. Moreover, Pterocladia appears to be rich in saturated fatty acids (69%) with palmitic acid as major fatty acid and 31% of monounsaturated fatty acids. The extraction yields were 2.7% for sulfated galactans and 11.5% for carrageenan. In order to elucidate their structures, H¹ NMR spectroscopy was performed as well as Infra-Red spectroscopy which allowed us to reveal their functional groups. A study of the antioxidant effect by the electrolysis method showed a greater effect for sulfated galactans. Furthermore, the study of the anticoagulant effect by APTT test, activated partial thromboplastin time, showed more pronounced anticoagulant power of sulfated galactans. The results of the present study confirmed the potential use of the red algae Pterocladia as a source of active known molecules.